GRI Bio Inc
GRI
Get informed when a big investor buys or sells
+ FollowMarket Cap$173.38K
Close$
$15.73
631.4% upside
Current Fair Value
631.4% upsideUndervalued by 631.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $173,376.00 |
|---|---|
| Enterprise Value | $-10,816,624.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-121.8 |
| Beta | -0.66 |
| Outstanding Shares | 1,804,951 |
Return
| Return on Equity | -103.44% |
|---|---|
| Return on Assets | -96.20% |
| Return on Invested Capital | -103.58% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | 0.13 |
| Price to Sales | - |
| Price to Book Ratio | 0.43 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.99 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-1.19
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
$-0.84
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.18%▲ 2.91% |
|---|---|
| Total Invested | $164,691▲ 154.73% |
| Investors Holding | 11▲ 5.00% |
ESG Score
No data
About GRI Bio Inc
2 employees